Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 2020-08, Vol.33 (4), p.235-238
Hauptverfasser:	Mitchell, Jolyon P, Berlinski, Ariel, Canisius, Sebastian, Cipolla, David, Dolovich, Myrna B, Gonda, Igor, Hochhaus, Guenther, Kadrichu, Nani, Lyapustina, Svetlana, Mansour, Heidi M, Darquenne, Chantal, Clark, Andy R, Newhouse, Michael, Ehrmann, Stephan, Humphries, Robert, Boushey, Homer
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Aerosols Betacoronavirus Coronavirus Infections - drug therapy COVID-19 Decision Making Health technology assessment Human health and pathology Humans Life Sciences Pandemics Pneumonia, Viral - drug therapy Pulmonology and respiratory tract SARS-CoV-2 Societies, Medical Standardization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!